Core Scientific (CORZ) Equity Ratio (2020 - 2026)

Core Scientific (CORZ) has 7 years of Equity Ratio data on file, last reported at 0.43 in Q1 2026.

• Quarterly Equity Ratio fell 106.34% year-over-year to 0.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.43 (down 106.34% YoY) and the FY2025 annual result came in at 0.41, up 35.82% from the prior year.
• Equity Ratio retreated to 0.43 in Q1 2026 per CORZ's latest filing, from 0.41 in the prior quarter.
• The five-year high for Equity Ratio was 0.42 in Q1 2022, with the low at 1.78 in Q2 2024.
• Average Equity Ratio over 5 years is 0.49, with a median of 0.52 recorded in 2023.
• Year-over-year, Equity Ratio jumped 135.38% in 2022 and sank 1241.14% in 2023.
• Core Scientific's Equity Ratio stood at 0.51 in 2022, then plunged by 65.39% to 0.84 in 2023, then increased by 23.77% to 0.64 in 2024, then soared by 35.82% to 0.41 in 2025, then retreated by 3.73% to 0.43 in 2026.
• Business Quant data shows CORZ's Equity Ratio at 0.43 in Q1 2026, 0.41 in Q4 2025, and 0.58 in Q3 2025.